Zenlabs EthicaBOM:530697 +4.97%60 Gross Margin % is 33.88% as of Mar. 2026, which is 66% above its 10-year median of 20.41. GuruFocus rates BOM:530697 with a GF Score™ of 60/100 and a GF Value™ of ₹29.26 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 116 Medical Distribution companies, Zenlabs Ethica ranks better than 67.24% on this metric.
The historical rank and industry rank for Zenlabs Ethica's Gross Margin % or its related term are showing as below:
BOM:530697'
s Gross Margin % Range Over the Past 10 Years
Min: 17.5 Med: 20.41 Max: 27.62
Current: 27.55
During the past 13 years, the highestGross Margin % of Zenlabs Ethica was 27.62%. The lowest was 17.50%. And the median was 20.41%.
BOM:530697's Gross Margin % is ranked better than 67.24% of 116
companies
in the Medical Distribution industry
Industry Median: 14.9
vs BOM:530697: 27.55
Zenlabs Ethica had a gross margin of 33.88% for the quarter that ended in Mar. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Zenlabs Ethica was 11.20% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Zenlabs Ethica had a gross margin of 33.88% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Zenlabs Ethica Gross Margin % Related Terms
Zenlabs Ethica Gross Margin % Historical Data
* Premium members only.
The historical data trend for Zenlabs Ethica's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:530697 vs MCK, CAH, COR: Gross Margin % Comparison
For the Medical Distribution subindustry, Zenlabs Ethica's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zenlabs Ethica Gross Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Zenlabs Ethica's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Zenlabs Ethica's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Zenlabs Ethica (BOM:530697) has a Gross Margin % of 33.88% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Zenlabs Ethica and its competitors. This is 66% above median its historical median of 20.41. Over the past decade, Zenlabs Ethica's Gross Margin % has ranged from 17.50 to 27.62. According to the industry distribution chart, Zenlabs Ethica ranks #38 out of 116 companies in the Medical Distribution industry, placing it in the top 32.8%.
Is Zenlabs Ethica's Gross Margin % too high?
Zenlabs Ethica's current Gross Margin % of 33.88% is 66% above median its 10-year median of 20.41. Over the past 10 years, this metric has ranged from a low of 17.50 to a high of 27.62. The Medical Distribution industry median Gross Margin % is 14.90. Zenlabs Ethica's value of 33.88% is 127.4% above this industry median. Based on the distribution chart, Zenlabs Ethica ranks #38 out of 116 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Zenlabs Ethica has a GF Score™ of 60/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zenlabs Ethica's Gross Margin % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Zenlabs Ethica ranks #38 out of 116 companies for Gross Margin %. This puts Zenlabs Ethica in the upper half of its industry. The industry median Gross Margin % is 14.90. Zenlabs Ethica's value of 33.88% is 127.4% above this benchmark. Historically, Zenlabs Ethica's own Gross Margin % has ranged from 17.50 to 27.62 over the past decade. While the company's 10-year median is 20.41 vs. the industry median of 14.90, Zenlabs Ethica has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Distribution company?
The median Gross Margin % among Medical Distribution companies is 14.90, based on 116 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zenlabs Ethica's current Gross Margin % of 33.88% is 127.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Zenlabs Ethica and its competitors. For the Medical Distribution industry, the median Gross Margin % is 14.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zenlabs Ethica's current Gross Margin % is 33.88%, which is 66% above median its own 10-year median of 20.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenlabs Ethica stock overvalued right now?
Based on GuruFocus' analysis, Zenlabs Ethica (BOM:530697) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹29.26, compared to a current price of ₹34.85 — trading 19.1% above its estimated fair value. The current Gross Margin % is 33.88%, which is 66% above median its 10-year median of 20.41 and 127.4% above the Medical Distribution industry median of 14.90. Zenlabs Ethica's overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Zenlabs Ethica (BOM:530697), the current Gross Margin % is 33.88% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zenlabs Ethica (BOM:530697) Overvalued in 2026?
Based on GuruFocus' analysis, Zenlabs Ethica stock appears to be overvalued.
The current stock price of ₹34.85 is trading 19.1% above its estimated GF Value™ of ₹29.26.
GuruFocus considers Zenlabs Ethica to be Modestly Overvalued.
Key valuation signals for BOM:530697:
Gross Margin %: 33.88% (66% above median its 10-year median of 20.41)
GF Value™: ₹29.26 vs. price of ₹34.85 (19.1% above fair value)
Industry Position: 127.4% above the Medical Distribution median (#38 of 116)
No single metric tells the full story. See the BOM:530697 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zenlabs Ethica Ltd is a pharmaceutical company engaged in the trading of pharmaceutical formulations. It manufactures and markets drugs which include Gastrointestinal disorders, anti-diabetics, anti-hypertensive drugs, anti-infective, soaps, and anti-Bacterial drugs, nutraceuticals, and others. In addition, The company offers more than 600 products across therapeutic segments.
60GF Score
Get the complete analysis for BOM:530697
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:530697 has been successfully added to your 
